Not checked for notices yet.
Efficacy and biomarker analysis of CD133-directed CAR T cells in advanced hepatocellular carcinoma: a single-arm, open-label, phase II trial
Hanren Dai, Chuan Tong, Daiwei Shi and 7 more
OncoImmunology · 2020
doi:10.1080/2162402x.2020.1846926
Cited by papers we hold 4
- Hepatocellular carcinoma: signaling pathways and therapeutic advances · 2025No notice
- Current challenges and therapeutic advances of CAR-T cell therapy for solid tumors · 2024No notice
- CAR-cell therapy in the era of solid tumor treatment: current challenges and emerging therapeutic advances · 2023No notice
- Immunotherapy for Hepatocellular Carcinoma: Current Status and Future Prospects · 2021No notice
Reads
Read by people on this page
None yet.
Checked or read by AI through naulon
None yet.
A person counts once a day per paper. We keep no cookie and no address: a reader is a hash that changes every day. Any month under five reads shows no number.
Are you an author?
Is this your paper?
Claim it to add your note and be paid when agents cite it. Free.